Takeda Pharmaceutical Company Limited
4502
Rang in Aktien
#377
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Aktienkurs
$40.31
Marktkapitalisierung
$64.13B
Veränderung (1 Tag)
0.82%
Veränderung (1 Jahr)
42.59%
Land
JP
Handel Takeda Pharmaceutical Company Limited (4502)
Kategorie
Healthcare
Aktien-Split-Historie für Takeda Pharmaceutical Company Limited (4502)
Die Aktie Takeda Pharmaceutical Company Limited (Symbol: 4502) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 22, 2026 statt.
Eine 4502-Aktie, die vor dem Oct 22, 2026 gekauft wurde, entspricht heute 0 4502-Aktien.
Der letzte Aktiensplit fand am Oct 22, 2026 statt.
Eine 4502-Aktie, die vor dem Oct 22, 2026 gekauft wurde, entspricht heute 0 4502-Aktien.
Liste der Aktiensplits
| Jahr | Aktien-Split | Multiplikator | Kumulierter Multiplikator |
|---|---|---|---|
| Nicht genügend Daten für die angegebenen Daten. | |||
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Aktiensplits | Kumulierter Multiplikator | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
|
| 0 | - |
CN
|
